Gaynor JJ and Ciancio G |
The Importance of Using Serially Measured Tacrolimus Clearance Values, Especially During the Early Posttransplantation Period. |
2018 |
Transplantation |
pmid:29271869
|
Shivaswamy V et al. |
Tacrolimus and sirolimus induce reproductive abnormalities in female rats. |
2011 |
Transplantation |
pmid:21508897
|
Cvetkovic M et al. |
The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. |
1994 |
Transplantation |
pmid:7513912
|
Selzner N et al. |
Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome. |
2009 |
Transplantation |
pmid:19935376
|
Rush DN et al. |
Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetil. |
2009 |
Transplantation |
pmid:19935461
|
Gayowski T et al. |
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. |
1998 |
Transplantation |
pmid:9500623
|
Neylan JF |
Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. |
1998 |
Transplantation |
pmid:9500626
|
D'Antiga L et al. |
Late cellular rejection in paediatric liver transplantation: aetiology and outcome. |
2002 |
Transplantation |
pmid:11792983
|
Propper DJ et al. |
FK506--its influence on anti-class 1 MHC alloantibody responses to blood transfusions. |
1990 |
Transplantation |
pmid:1696409
|
Gupta A et al. |
Elevated myeloid: plasmacytoid dendritic cell ratio associates with late, but not early, liver rejection in children induced with rabbit anti-human thymocyte globulin. |
2009 |
Transplantation |
pmid:19696644
|
Gerlach UA et al. |
Intragraft and Systemic Immune Parameters Discriminating Between Rejection and Long-Term Graft Function in a Preclinical Model of Intestinal Transplantation. |
2017 |
Transplantation |
pmid:27607529
|
Jain A et al. |
FK506 and pregnancy in liver transplant patients. |
1993 |
Transplantation |
pmid:7506459
|
Kessler M et al. |
A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus. |
1999 |
Transplantation |
pmid:10071045
|
Rostaing L et al. |
Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. |
2005 |
Transplantation |
pmid:15818323
|
di Francesco F et al. |
One year follow-up of steroid-free immunosuppression plus everolimus in isolated pancreas transplantation. |
2008 |
Transplantation |
pmid:18946356
|
Mahé E et al. |
Drug-induced hypersensitivity syndrome associated with primary Epstein-Barr virus and human herpesvirus 6 infections in a child intestinal transplant recipient. |
2004 |
Transplantation |
pmid:14966435
|
Paramesh AS et al. |
Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation. |
2004 |
Transplantation |
pmid:14724447
|
Jain AB et al. |
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. |
1998 |
Transplantation |
pmid:9825817
|
Gruessner RW and Sharp HL |
Living-related intestinal transplantation: first report of a standardized surgical technique. |
1997 |
Transplantation |
pmid:9415566
|
Shackleton CR et al. |
Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipients. |
1995 |
Transplantation |
pmid:7570950
|
Piao SG et al. |
Combined treatment of tacrolimus and everolimus increases oxidative stress by pharmacological interactions. |
2014 |
Transplantation |
pmid:24825522
|
Gujadhur A et al. |
CMV sinusitis in a HIV-negative renal transplant recipient. |
2014 |
Transplantation |
pmid:24827770
|
Takatsuki M et al. |
Weaning of immunosuppression in living donor liver transplant recipients. |
2001 |
Transplantation |
pmid:11502975
|
Riegersperger M et al. |
Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long-term kidney transplant recipients. |
2013 |
Transplantation |
pmid:23594858
|
Poncelet AJ et al. |
Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus. |
2008 |
Transplantation |
pmid:19077894
|
Uchida N et al. |
Mycophenolate and tacrolimus for graft-versus-host disease prophylaxis for elderly after cord blood transplantation: a matched pair comparison with tacrolimus alone. |
2011 |
Transplantation |
pmid:21677598
|
Josephson MA et al. |
Treatment of renal allograft polyoma BK virus infection with leflunomide. |
2006 |
Transplantation |
pmid:16534472
|
Hariharan S |
Case 2: strategies to minimize the use of calcineurin inhibitors (CNIs). |
2002 |
Transplantation |
pmid:12357988
|
Wu MJ et al. |
Lower variability of tacrolimus trough concentration after conversion from prograf to advagraf in stable kidney transplant recipients. |
2011 |
Transplantation |
pmid:21912349
|
Stempfle HU et al. |
The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. |
2002 |
Transplantation |
pmid:11889427
|
van Maarseveen EM et al. |
Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: a pilot study. |
2013 |
Transplantation |
pmid:23250333
|
Charpentier B et al. |
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. |
2003 |
Transplantation |
pmid:12660513
|
Marks WH et al. |
Asialoglycoprotein/asialoglycoprotein receptor (AGP-AGPr) interaction is an important mechanism for the uptake of FK506 by hepatocytes. |
1997 |
Transplantation |
pmid:9020333
|
Kim SJ et al. |
A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients. |
2006 |
Transplantation |
pmid:17038908
|
Farley DE et al. |
The effect of two new immunosuppressive agents, FK506 and didemnin B, in murine pregnancy. |
1991 |
Transplantation |
pmid:1713360
|
Deuse T et al. |
Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545. |
2012 |
Transplantation |
pmid:22971540
|
Jain A et al. |
One thousand consecutive primary liver transplants under tacrolimus immunosuppression: a 17- to 20-year longitudinal follow-up. |
2011 |
Transplantation |
pmid:21378604
|
Gruessner RW et al. |
Portal donor-specific blood transfusion and mycophenolate mofetil allow steroid avoidance and tacrolimus dose reduction with sustained levels of chimerism in a pig model of intestinal transplantation. |
2004 |
Transplantation |
pmid:15239611
|
Tsamandas AC et al. |
Central venulitis in the allograft liver: a clinicopathologic study. |
1997 |
Transplantation |
pmid:9256183
|
Margreiter R et al. |
A double-hand transplant can be worth the effort! |
2002 |
Transplantation |
pmid:12134104
|
Wiesner RH |
A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group. |
1998 |
Transplantation |
pmid:9734494
|
Yashima J et al. |
Successful conversion from tacrolimus to cyclosporine after kidney transplantation. |
2000 |
Transplant. Proc. |
pmid:11119895
|
Kumai Y et al. |
Reversible Cerebral Vasoconstriction Syndrome After Heart Transplantation: A Case Report. |
2017 |
Transplant. Proc. |
pmid:29198694
|
Machado PG et al. |
Use of reduced dose of OKT3 (2.5 mg) after renal transplantation. |
2002 |
Transplant. Proc. |
pmid:11959207
|
Kinoshita I et al. |
Immunosuppression with FK 506 insures good success of myoblast transplantation in MDX mice. |
1994 |
Transplant. Proc. |
pmid:7527978
|
Porayko MK et al. |
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7679835
|
Iwasaki K et al. |
Pharmacokinetic study of FK 506 in the rat. |
1991 |
Transplant. Proc. |
pmid:1721268
|
Andersson J et al. |
FK 506 and cyclosporine inhibit antigen- or mitogen-induced monokine and lymphokine production in vitro. |
1992 |
Transplant. Proc. |
pmid:1371621
|
Takada S et al. |
HGF prevents tacrolimus (FK 506)-induced nephrotoxicity in SHR rats. |
1996 |
Transplant. Proc. |
pmid:8623236
|
Monden M et al. |
A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates. |
1990 |
Transplant. Proc. |
pmid:1689904
|
Videla CO |
Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715995
|
Mazali FC et al. |
Posttransplant diabetes mellitus: incidence and risk factors. |
2008 |
Transplant. Proc. |
pmid:18455010
|
Koyamada N et al. |
Strategy for chronic rejection in recipient of living-related liver transplantation. |
2000 |
Transplant. Proc. |
pmid:11120102
|
Kohnle M et al. |
Conversion from cyclosporine to tacrolimus in renal transplant recipients with gum hyperplasia. |
1999 |
Transplant. Proc. |
pmid:10576043
|
Alloway RR et al. |
Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. |
1996 |
Transplant. Proc. |
pmid:8623494
|
Dumont FJ et al. |
Up-regulation of gene expression by FK 506. |
1991 |
Transplant. Proc. |
pmid:1721300
|
Meçule A et al. |
Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors. |
2010 |
Transplant. Proc. |
pmid:20534290
|
Burke GW et al. |
Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction. |
1998 |
Transplant. Proc. |
pmid:9636627
|
Bakar F et al. |
Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus. |
2009 |
Transplant. Proc. |
pmid:19545695
|
Ushigome H et al. |
Two cases of tacrolimus-induced alopecia following kidney transplantation. |
1999 |
Transplant. Proc. |
pmid:10578326
|
Takara T et al. |
Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506. |
1994 |
Transplant. Proc. |
pmid:7518150
|
Shibutani S et al. |
FK 506 abrogates induction of regulatory cells after intratracheal delivery of alloantigen. |
2002 |
Transplant. Proc. |
pmid:12176432
|
Jain A et al. |
Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. |
1992 |
Transplant. Proc. |
pmid:1376518
|
Watanabe K et al. |
Factors influencing long-term operational tolerance in dogs treated with fractionated lymphoid irradiation, donor bone marrow cell infusion and FK506. |
1995 |
Transplant. Proc. |
pmid:7533389
|
Borg AJ and Kumagai M |
FK 506 and xenogeneic human anti-porcine cellular reactivity. |
1991 |
Transplant. Proc. |
pmid:1721332
|
Hoshinaga K et al. |
Regimen of tacrolimus-based immunosuppression with basiliximab, mycophenolate mofetil, and low-dose steroid reduces acute rejection in kidney transplants. |
2005 |
Transplant. Proc. |
pmid:15919457
|
Signorell J et al. |
Recurrent non-melanoma skin cancer: remission of field cancerization after conversion from calcineurin inhibitor- to proliferation signal inhibitor-based immunosuppression in a cardiac transplant recipient. |
2010 |
Transplant. Proc. |
pmid:21094874
|
Altaca G et al. |
Effect of low-dose calcineurin inhibitors on acute rejection and graft survival. |
2002 |
Transplant. Proc. |
pmid:12270320
|
Regazzi MB et al. |
Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation. |
1997 |
Transplant. Proc. |
pmid:9142302
|
Squifflet JP et al. |
Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study. |
2002 |
Transplant. Proc. |
pmid:12176495
|
Jensen CW et al. |
Pediatric renal transplantation under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721364
|
McCauley J et al. |
The question of FK 506 nephrotoxicity after liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1703344
|
Ko WJ et al. |
Clinical trial of FK506 in heart transplant patients in Taiwan: report of 7 cases with immunosuppression switch from cyclosporine to FK506. |
1998 |
Transplant. Proc. |
pmid:9838474
|
Takayama K et al. |
Nonmuscle myosin heavy chain and nuclear factor-kappa B expression in pig-to-primate xenotransplanted hearts. |
2000 |
Transplant. Proc. |
pmid:10936372
|
Zmonarski S et al. |
Expression of PBMC TLR4 in Renal Graft Recipients Who Experienced Delayed Graft Function Reflects Dynamic Balance Between Blood and Tissue Compartments and Helps Select a Problematic Patient. |
|
Transplant. Proc. |
pmid:30056893
|
Zipperle S et al. |
Impaired T-cell IL-10 secretion and CD4 helper function in liver transplant patients treated with tacrolimus. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123208
|
Boots JM et al. |
Risk of adrenal insufficiency with steroid maintenance therapy in renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176541
|
Sato K et al. |
Pancreaticoduodenal allotransplantation with cyclosporine and FK506. |
1989 |
Transplant. Proc. |
pmid:2468212
|
Freise CE et al. |
Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. |
1991 |
Transplant. Proc. |
pmid:1721397
|
Klupp J et al. |
Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083497
|
Kim JM et al. |
Preemptive therapy in adult liver transplant recipients in CMV-endemic area. |
2010 |
Transplant. Proc. |
pmid:20430182
|
Cai W et al. |
Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients. |
2018 |
Transplant. Proc. |
pmid:29735215
|
Dette K et al. |
Daclizumab and ATG versus ATG in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous [correction of simultaneus] pancreas-kidney transplantation: analysis of early outcome. |
2002 |
Transplant. Proc. |
pmid:12176624
|
Zhang J et al. |
Chemotherapy for De Novo Gastric Adenocarcinoma After Deceased Orthotopic Liver Transplantation: A Case Report. |
|
Transplant. Proc. |
pmid:28104131
|
Zaltzman J et al. |
Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267183
|
Fukuzawa M et al. |
Effect of donor-specific transfusion and FK 506 on small intestine allotransplantation. |
1991 |
Transplant. Proc. |
pmid:1721427
|
Park KM et al. |
Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine. |
1996 |
Transplant. Proc. |
pmid:8658863
|
Venkataramanan R et al. |
Biopharmaceutical aspects of FK-506. |
1987 |
Transplant. Proc. |
pmid:2445070
|
Burrows L et al. |
Conversion to tacrolimus to ameliorate cyclosporine toxicity in kidney recipients. |
1998 |
Transplant. Proc. |
pmid:9723378
|
Fung JJ and Starzl TE |
FK 506 in solid organ transplantation. |
1994 |
Transplant. Proc. |
pmid:7524226
|
Rabkin JM et al. |
Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267411
|
McCauley J et al. |
FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome. |
1991 |
Transplant. Proc. |
pmid:1721459
|
Griffin AD et al. |
FK 506 in canine renal transplantation. |
1992 |
Transplant. Proc. |
pmid:1384209
|
McAlister VC |
Liposomal tacrolimus: drug migration within blood compartments. |
1998 |
Transplant. Proc. |
pmid:9636404
|
Zhang J et al. |
Value of CYP3A5 genotyping on determining initial dosages of tacrolimus for Chinese renal transplant recipients. |
2010 |
Transplant. Proc. |
pmid:21094797
|
Gotsman I et al. |
Effect of peripheral immune tolerance on liver-associated lymphocytes expressing NK1.1. |
2000 |
Transplant. Proc. |
pmid:10856569
|
Guleria S et al. |
Tacrolimus (Pan Graf) as de novo therapy in renal transplant recipients in India. |
2006 |
Transplant. Proc. |
pmid:16979989
|
Ericzon BG et al. |
Effect of FK 506 on glucose metabolism in the cynomolgus monkey: studies in pancreatic transplant recipients and nontransplanted animals. |
1991 |
Transplant. Proc. |
pmid:1703695
|
Blume C et al. |
Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750357
|
Busque S et al. |
Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis. |
1998 |
Transplant. Proc. |
pmid:9636507
|